Navigation Links
The Will and Jada Smith Family Foundation and Maybelline Join Forces With the Lupus Foundation of America for a Star-studded Gala to Raise Awareness for Lupus
Date:9/12/2007

LOS ANGELES, Sept. 12 /PRNewswire-USNewswire/ -- The Lupus Foundation of America (LFA) and Maybelline in association with the Will and Jada Smith Family Foundation is set to host the first annual Butterflies Over Hollywood soiree. The event, to be held at the historic El Rey Theatre in Los Angeles on September 29, 2007, has the specific purpose of raising awareness and funds for lupus.

Butterflies Over Hollywood will be hosted by Malcolm-Jamal Warner (The Cosby Show), and supermodel Tomiko Fraser -- who also created the event. Tomiko is currently in her unprecedented 8th year as the face of Maybelline(R) New York. Tomiko also proudly serves as a national spokesperson for the LFA in support of her sister -- who suffers from lupus. When asked what prompted her to create this event, Tomiko remarked, "I created this event out of the love for my sister. I also created this event because I feel that there needs to be more awareness for lupus, and I hope that by joining forces with Hollywood, we can shed some light on a disease that affects millions."

The LFA will transform the El Rey Theatre into a spectacular Cotton Club- themed night of glamour with special live performances, signature cocktails, and more. As Los Angeles has not seen a 1920's themed event of this caliber in recent history, Butterflies Over Hollywood is sure to be a highly sought after event for celebrities, raising both funds and awareness for lupus.

Lupus is a debilitating immune disorder that can damage any organ. Every half hour another person is diagnosed with lupus, and thousands die each year from its complications. Yet, there has not been a new drug approved for lupus in more than 40 years. The LFA estimates that 1.5-2 million Americans have a form of lupus, but the actual number may be higher. More than 90 percent of people with lupus are women, and currently there is no cure for the disease. The LFA is the nation's leading nonprofit health organization dedicated to find
'/>"/>

SOURCE Lupus Foundation of America
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. GlaxoSmithKline - Changes Lamictal(R) Label Appearance and Packaging
2. Iodex goes to SmithKline Beecham consumer Healthcare
3. GlaxoSmithKline To Cultivate Non-Smoking Environment
4. GlaxoSmithKline to Supply United States with 8 Million flu vaccine, Fluarix
5. FDA Mislead On Asthma Drug By GlaxoSmithKline
6. GlaxoSmithKline Defends Its Products
7. GlaxoSmithKline launches diabetes and cancer drugs
8. Generic Products Compete With GlaxoSmithKline
9. New Cervical Cancer Vaccine to Be Launched By Glaxo Smithkline
10. GlaxoSmithKline Agrees To Settle Paxil Claims For $14 million
11. GlaxoSmithKlines Zofran Helps In Treatment Of Dehydration In Children

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2009)... , , WASHINGTON, Nov. 21 /PRNewswire-USNews...e following statement upon the United States Senat...e Health Care legislation: ,, "Senators Arlen S...lphians and all Pennsylvanians for casting stand-u...President Obama,s historic Affordable Health Care ...
(Date:11/21/2009)... , , WASHINGTON, Nov. 21 /PRNewswire-USN...1990s to eliminate onchocerciasis (river blindness...evalence of the disease in recent years, as eviden... requiring mass drug administration in six endemic...th annual meeting of the American Society of Tropi...
(Date:11/21/2009)... , HAPPYneuron,s most pop...ble on the iPhone and iPod Touch. , ...2009 -- HAPPYneuron,s most popular and addictive g...d iPod Touch. Split Words is designed to help bani...,The SplitWords iPhone brain game challenges the...
(Date:11/20/2009)... , , PRINCETON, NJ, Nov. 20 /PRNewswire-F...d today that a Special Meeting of Shareholders wil...e of the Meeting is to consider approval of two sp... to approve and authorize the sale of all or subst...ly on the terms provided for in the asset purchase...
(Date:11/20/2009)... , , MADISON, N.J., Nov. 20 /PRNewswire... influenza virus may have peaked in late October, ...tial source of illness in all age groups, includin...Diagnostics Incorporated (NYSE: DGX ), the world...tion and services. ,, In its most recent Quest...
Breaking Medicine News(10 mins):Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 2Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 3Health News:River Blindness (Onchocerciasis) Reduced By Nearly One-Third In At-Risk Populations In Six Countries 4Health News:HAPPYneuron releases iPhone Brain Game 2Health News:HAPPYneuron releases iPhone Brain Game 3Health News:NUCRYST Announces Special Meeting of Shareholders 2Health News:NUCRYST Announces Special Meeting of Shareholders 3Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 2Health News:H1N1 Pandemic May Have Peaked in October in U.S., According to Quest Diagnostics 3
...lligence could be defined as the capacity to perce...d those of others so as to be able to distinguish ...de for one,s thoughts and actions. One of the impo...tural world more effectively. , The Stress and He...
...side-Naive Chronic Hepatitis B e-Antigen (HBeAg) ...d One Patient with Genotypic Resi...ers Squibb Company,(NYSE: BMY ) today announced d...e amount of hepatitis B virus in the,blood, or vir...
...lar Instruments, Inc.,developer and manufacturer o...ressure-volume (P-V) systems, today announced the ...mall and large animal models. The MPVS Ultra simu... transgenic mice to domestic livestock. Using,the ...
..., Inc. (Nasdaq:,CRYO), a medical device company fo...ounced today the appointment of Mark Adams as Vice...s to CryoCor over 20 years,of cardiac related medi... which was approved by the FDA in August 2007,for ...
...Corporation (Nasdaq:,DNDN) will release its third ... 2007. Company management will host a conference c...ial results and provide a general,corporate update...tic) or +1-719-325-4876 (international) Webcast: ...
...2 Progen,Pharmaceuticals Limited (ASX: PGL; Nasda...nt Fast Track designation awarded to PI-88 for the...e resection of primary,liver cancer and in order t...has used the Special Protocol Assessment (SPA) pro...
Other Medicine News:Health News:Emotional Intelligence and the use of tobacco and cannabis 2Health News:Ninety-one Percent of BARACLUDE(R) (entecavir) Treated Patients in a Four-Year Cohort Demonstrated Virologic Suppression to Undetectable Levels 2Health News:Ninety-one Percent of BARACLUDE(R) (entecavir) Treated Patients in a Four-Year Cohort Demonstrated Virologic Suppression to Undetectable Levels 3Health News:Ninety-one Percent of BARACLUDE(R) (entecavir) Treated Patients in a Four-Year Cohort Demonstrated Virologic Suppression to Undetectable Levels 4Health News:Ninety-one Percent of BARACLUDE(R) (entecavir) Treated Patients in a Four-Year Cohort Demonstrated Virologic Suppression to Undetectable Levels 5Health News:Ninety-one Percent of BARACLUDE(R) (entecavir) Treated Patients in a Four-Year Cohort Demonstrated Virologic Suppression to Undetectable Levels 6Health News:Millar Instruments Launches Complete Pressure-Volume System for Large and Small Animal Models 2Health News:CryoCor Appoints New Vice President of Sales and Marketing 2Health News:CryoCor Appoints New Vice President of Sales and Marketing 3Health News:CryoCor Appoints New Vice President of Sales and Marketing 4Health News:-Dendreon to Hold Conference Call on Thursday, November 15, 2007 at 4:30 PM ET- 2Health News:Progen Update on Phase 3 Clinical Program for PI-88 in Liver Cancer 2Health News:Progen Update on Phase 3 Clinical Program for PI-88 in Liver Cancer 3
(Date:11/20/2009)...v. 20 Cornerstone Therap...utical company focused on acquiring, developing an...or the respiratory and related markets, today repo...e Food and Drug Administration ("FDA") alleging th... HCl 10 mg, Pyrilamine Maleate 16 mg) and Deconsal...
(Date:11/20/2009)... Nov. 20 /PRNewswire-FirstCall/ -- Landauer, In...he fiscal fourth quarter and full year of 2009 pre...mpany will host a conference call for investors on...ime. Investors may access the live call by dialing...), or 480-629-9835 (international callers), or by ...
(Date:11/20/2009)...a., Nov. 20 The Departm...shots to members of priority groups that did not h...of 18 clinics are being held statewide on Nov. 20-.... Hours on Saturday, Nov. 21, will be 8 a.m. to 2 ...from 2 p.m. to 8 p.m. ,, Individuals in the re...
Breaking Medicine Technology:Cornerstone Therapeutics Provides a Response to FDA Warning Letter on Deconsal 2Cornerstone Therapeutics Provides a Response to FDA Warning Letter on Deconsal 3Landauer, Inc. Sets Date and Time for Announcement of Fiscal Fourth Quarter and Full Year 2009 Results 2Pennsylvania Department of Health Begins Statewide H1N1 Vaccination Clinics Targeting Priority Populations; Some Appointments Still Available 2HealthyFeetStore com Celebrates 5th Anniversary 61506 1HealthyFeetStore com Celebrates 5th Anniversary 61506 2New HIMSS Analytics Survey Reveals Healthcare Business Associates Are Unprepared for Data Breach 61502 1New HIMSS Analytics Survey Reveals Healthcare Business Associates Are Unprepared for Data Breach 61502 2New HIMSS Analytics Survey Reveals Healthcare Business Associates Are Unprepared for Data Breach 61502 3Vivakor Inc Announces Stock Dividend 14870 1Vivakor Inc Announces Stock Dividend 14870 2Vivakor Inc Announces Stock Dividend 14870 3Vivakor Inc Announces Stock Dividend 14870 4
...(Nasdaq:,DNDN) will host a conference call today, ... to review the outcome of the interim analysis of ...oma Treatment, also known as D9902B),clinical tria...estigational,active cellular immunotherapy for the...interested may access the call with the following ...
...ewest study site, PHILADELPHIA, Oct. 3 The Child...ntract to manage a new study site in The,National ...local,participation, recruitment and data collecti...funded by the National Institutes of Health., Inv... in Burlington,County will participate in the stud...
Other Medicine Technology:Dendreon to Hold a Conference Call Today at 9:00 AM ET to Provide an Update on Interim Results of Phase 3 PROVENGE IMPACT Trial 2The Children's Hospital of Philadelphia Announces New Regional Participant in The National Children's Study 2
1.0mm Trephine with Handle
3.5mm Trephine with Handle
8.0mm Calibrated Trephine Handle
7.25mm Calibrated Trephine Handle
Medicine Products: